Regulation

Opella: Unlock Volume Growth By Expanding Access And Deepening Category Penetration

 
• By 

Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.

Like Claims Of Prenatal Acetaminophen Exposure Risks, Petition For Warning Is ‘Unreliable’ – CHPA

 

Scientific literature on potential link between prenatal acetaminophen exposure and neurological conditions “now includes FDA’s most recent epidemiological review” completed in May saying research results “insufficient to support a causal association.”

Norway Decides Against Tighter Restrictions For Ibuprofen

 
• By 

Norway's Medical Products Agency has rejected claims that misuse of OTC ibuprofen is linked to its availability for purchase in outlets other than pharmacies.

Latest OTC Eye Drop Production Problem In US Prompts Firm To Close Doors After Recalls

 

BRS Analytical Services in St. Louis recalled more than 75,000 cases of redness and lubricating eye drops and committed “to permanently cease production of all drugs.”


US FDA Plans Move Inspectorate Back To More Generalist Organization

 

The “Simple Reform” initiative would reverse a 2017 move to ensure FDA investigators were experts in the commodity they inspected or in clinical research regulations.

RFK Jr. Ally Authors Citizen Petition For Label Warnings Of Prenatal Acetaminophen Exposure

 

Informed Consent Action Network requests warning on acetaminophen-containing OTC monograph drugs in petition submitted by Siri & Glimstad LLP, where partner Aaron Siri has provided legal counsel for HHS Secretary Kennedy. Tylenol marketer Kenvue disputes ICAN’s conclusions and its grasp of FDA regul

US FDA Could Use Shutdown To Improve As Foreign Agencies Compete For Regulatory Lead

 

Panelists at the BioFuture conference discussed the potential opportunities the government shutdown creates for the FDA to improve flexibility and efficiency.

‘You Are Very Regulated’: Consumer Health And Beauty Industries’ Attention Needed In California

 

Regulations likely holding consumer product firms’ attention include the Plastic Pollution Prevention and Packaging Producer Responsibility Act, SB 54, scheduled to become effective by 2027. “Easily the most significant, extended producer responsibility law ever to pass in the world,” says lobbyist


US FDA Independence Questioned At CDC Oversight Hearing

 

A Senate committee is investigating leadership changes at the US Centers for Disease Control and Prevention. While the primary focus is vaccine policy, the first hearing suggested the probe could raise questions about FDA independence.

New UK Toothpaste Tubes Now 100% Recyclable

 
• By 

Haleon, Colgate-Palmolive and other manufacturers have changed the way they manufacturer toothpaste tubes to be sold in the UK so they can be all be technically recycled.

US FDA Facility Inspections, Website Reviews Paused With FY 2026 Budget On Hold

 

Continuing work includes “for cause and certain surveillance inspections of regulated facilities” and “criminal enforcement work and certain civil investigations” as White House mulls layoffs rather than furloughs during federal government shutdown.

OMUFA Reauthorization: US FDA Would Identify Rx-OTC Switch Candidates, Work With Sponsors

 
• By 

Senate “SMART OTC” Act would require the FDA to identify product categories that could be eligible for an Rx-to-OTC switch and create a framework to work with sponsors.


Women’s Health: Tranexamic Acid Now Available OTC In France

 
• By 

Cemag Care may be behind the recent Rx-to-OTC switch of menstrual health treatment tranexamic acid (1000mg) in France.

US FDA Notes Honey Drops Eye Care, Nasal Spray Brain Boost In Recent Warning Letters

 

Recent FDA warning letters hit typical problems in consumer health space such as manufacturing quality control deficiencies, but also note honey offered for eye infections and nasal spray to enhance cognitive function.

Perrigo: Women’s Health Innovation Must Involve Women, Right From The Start

 
• By 

“Women's health isn't a niche area," noted Perrigo’s Alison Slingsby at Lynx2Market’s PharmaSynergyOTC event in Rome. Slingsby offers advice from the firm's experience in delivering some of the most innovative women's health Rx-to-OTC switches.

Complete Response Letters: Will Industry Fight US FDA’s Disclosure Plans?

 
• By 

FDA's release of CRLs for unapproved products could bring a court challenge, but for now, sponsors should expect all past and future letters will be made public, experts said.


European Regulators And Industry Stand By Paracetamol Safety After US Warning

 
• By 

EMA and MHRA among European regulators reiterating the safety of paracetamol use by pregnant women following news FDA will require OTCs to carry label warning.

Medical Groups Dismiss Trump’s ‘Event On Autism’

 

Among critics of Trump administration's moves, American Academy of Pediatrics says “White House event on autism was filled with dangerous claims and misleading information.”

Attorney For Autistic Children’s Families: Additional Acetaminophen Label Warning Not Needed

 

“I knew when I was pregnant with my kids the first thing, I knew from just talking to my other friends, before you take anything when you're pregnant, you go to talk to your doctor. I think that's what most pregnant women do,” says regulatory attorney Christine Lawson.

Japan Approves OTC Sale Of Emergency Contraceptive Pill

 
• By 

Aska Pharmaceutical has recieved a green light from Japan’s Ministry of Health, Labour and Welfare for the Rx-to-OTC switch of its NorLevo (1.5mg levonorgestrel) emergency contraceptive. Controversially, OTC NorLevo will need to be taken on the spot by purchasers in the presence of a pharmacist.